Clinical Trials Browser

OTHER_GOV × Breast Neoplasms × pyrotinib × Clear all

NCT05769010 2026-04-01

Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

Phase 2 Recruiting

Breast Neoplasms

NCT05328440 2023-09-25

Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)

Phase 2 Unknown

Breast Neoplasms

NCT04293276 2023-05-06

DAP-Her-01

Phase 2 Unknown

Breast Neoplasms